Jennison Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $139M | Sell |
|
|||||
|
2025
Q2 | $114M | Buy |
|
|||||
|
2025
Q1 | $83.5M | Buy |
|
|||||
|
2024
Q4 | $61.2M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $53M | Sell |
|
|||||
|
2016
Q2 | $54.1M | Buy |
|
|||||
|
2016
Q1 | $60.9M | Sell |
|
|||||
|
2015
Q4 | $140M | Buy |
|
|||||
|
2015
Q3 | $119M | Buy |
|
|||||
|
2015
Q2 | $114M | Buy |
|
|||||
|
2015
Q1 | $98.8M | Buy |
|
|||||
|
2014
Q4 | $91.5M | Sell |
|
|||||
|
2014
Q3 | $75.1M | Buy |
|
|||||
|
2014
Q2 | $60.7M | Sell |
|
|||||
|
2014
Q1 | $70.6M | Buy |
|
|||||
|
2013
Q4 | $65.5M | Sell |
|
|||||
|
2013
Q3 | $72.5M | Buy |
|
|||||
|
2013
Q2 | $30.6M | Buy |
|